365 related articles for article (PubMed ID: 32786511)
1. Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces.
Singh N; Chaput L; Villoutreix BO
J Chem Inf Model; 2020 Aug; 60(8):3910-3934. PubMed ID: 32786511
[TBL] [Abstract][Full Text] [Related]
2. A Hybrid Docking and Machine Learning Approach to Enhance the Performance of Virtual Screening Carried out on Protein-Protein Interfaces.
Singh N; Villoutreix BO
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430841
[TBL] [Abstract][Full Text] [Related]
3. Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation.
Nayarisseri A; Khandelwal R; Madhavi M; Selvaraj C; Panwar U; Sharma K; Hussain T; Singh SK
Curr Top Med Chem; 2020; 20(24):2146-2167. PubMed ID: 32621718
[TBL] [Abstract][Full Text] [Related]
4. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
Shin WH; Christoffer CW; Kihara D
Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
[TBL] [Abstract][Full Text] [Related]
5. An online repository of solvation thermodynamic and structural maps of SARS-CoV-2 targets.
Olson B; Cruz A; Chen L; Ghattas M; Ji Y; Huang K; Ayoub S; Luchko T; McKay DJ; Kurtzman T
J Comput Aided Mol Des; 2020 Dec; 34(12):1219-1228. PubMed ID: 32918236
[TBL] [Abstract][Full Text] [Related]
6. Optimization Rules for SARS-CoV-2 M
Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
[TBL] [Abstract][Full Text] [Related]
7. Establishment and validation of a drug-target microarray for SARS-CoV-2.
Chen P; Zeng Z; Du H
Biochem Biophys Res Commun; 2020 Sep; 530(1):4-9. PubMed ID: 32828312
[TBL] [Abstract][Full Text] [Related]
8. Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors.
Sable R; Jois S
Molecules; 2015 Jun; 20(6):11569-603. PubMed ID: 26111183
[TBL] [Abstract][Full Text] [Related]
9. In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances.
Kuenemann MA; Sperandio O; Labbé CM; Lagorce D; Miteva MA; Villoutreix BO
Prog Biophys Mol Biol; 2015 Oct; 119(1):20-32. PubMed ID: 25748546
[TBL] [Abstract][Full Text] [Related]
10.
Domenico A; Nicola G; Daniela T; Fulvio C; Nicola A; Orazio N
J Chem Inf Model; 2020 Oct; 60(10):4582-4593. PubMed ID: 32845150
[TBL] [Abstract][Full Text] [Related]
11. Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.
Zhao Z; Bourne PE
J Proteome Res; 2020 Nov; 19(11):4698-4705. PubMed ID: 32946692
[TBL] [Abstract][Full Text] [Related]
12. Identification of Inhibitors for the Lutheran Blood Group Glycoprotein - Laminin 511/521 Interaction by Molecular Modelling and Simulation Techniques.
Madeleine N; Gardebien F
Curr Comput Aided Drug Des; 2018; 14(3):253-268. PubMed ID: 27439722
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0.
Gervasoni S; Vistoli G; Talarico C; Manelfi C; Beccari AR; Studer G; Tauriello G; Waterhouse AM; Schwede T; Pedretti A
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708196
[TBL] [Abstract][Full Text] [Related]
14. Benchmark Study Based on 2P2I
Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
[TBL] [Abstract][Full Text] [Related]
15. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
16. Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach.
Murugan NA; Kumar S; Jeyakanthan J; Srivastava V
Sci Rep; 2020 Nov; 10(1):19125. PubMed ID: 33154404
[TBL] [Abstract][Full Text] [Related]
17. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A
Molecules; 2020 May; 25(11):. PubMed ID: 32485894
[TBL] [Abstract][Full Text] [Related]
18. Investigation of MM-PBSA rescoring of docking poses.
Thompson DC; Humblet C; Joseph-McCarthy D
J Chem Inf Model; 2008 May; 48(5):1081-91. PubMed ID: 18465849
[TBL] [Abstract][Full Text] [Related]
19. A protein interaction map identifies existing drugs targeting SARS-CoV-2.
Cava C; Bertoli G; Castiglioni I
BMC Pharmacol Toxicol; 2020 Sep; 21(1):65. PubMed ID: 32883368
[TBL] [Abstract][Full Text] [Related]
20. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
Nadeau R; Shahryari Fard S; Scheer A; Hashimoto-Roth E; Nygard D; Abramchuk I; Chung YE; Bennett SAL; Lavallée-Adam M
J Proteome Res; 2020 Nov; 19(11):4553-4566. PubMed ID: 33103435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
